News

_____

Press Kit

Presentations

Publications

CorInnova in the News

Please reload

None of the statements or information contained on our website is an offer to buy or sell our securities. Offers to buy or sell our securities are made only pursuant to separate formal legal agreements. Nor should you make any investment decision based on the information on our website, but solely on that information contained in such legal agreements.

TMC Innovation Institute selects CorInnova for TMCx09 Medical Device Cohort

CorInnova invited to speak at BIOMEDevice Boston

CorInnova wins "Best Investment Potential - Top 3 All Industries" at 2019 Angel Capital Association Meeting

CorInnova Wins 2019 MedCity INVEST PitchPerfect Competition

Two TMC-Backed Startups Aim to Change the Way We Treat Failing Hearts

CorInnova's Preclinical results to date published in prestigious Journal for Translational Cardiovascular Research

CorInnova invited to speak at CSI D-HF Device Therapies for Heart Failure in Frankfurt

“STS/AATS Tech-Con 2018” – Sixth Honor in Five Months

CorInnova Wins Top Prize at “RESI San Francisco 2018” Innovation Challenge

CorInnova Awarded “2017 InnoSTARS” Prize for Non-Blood-Contacting, Soft Robotic Heart Assist Device as Alternative to LVAD Treatment of Heart Failure

CorInnova wins “Most Promising Life Science Company” award from Rice Alliance for Technology and Entrepreneurship at Texas Life Science Forum

CorInnova Selected to Present at TCT 2017 “Shark Tank” Competition

$6.1 Million Lead Investment from UK-based The Wellcome Trust is being Used to Develop Less-Invasive, Non-Blood-Contacting Soft Robotic Heart Device to Treat Heart Failure.

CorInnova Awarded Seminal Patent for Minimally Invasively-Delivered Soft Robotic Heart Device to Support Heart Function

Company Announces Residency at Johnson & Johnson Innovation’s JLABS @ TMC in the Texas Medical Center

Please reload